GlaxoSmithKline Consumer Healthcare Australia, in consultation with the TGA, is recalling 3 batches of Children’s Panadol 5-12 years suspension, 200 mL bottles.
An ingredient used in the manufacture of these medicines may have been contaminated with small particles that could contain trace minerals and inert fibres. The quantity of these particles would be small and they may not be visible in the product. If this occurs, there is a very low risk of allergic reaction and potentially the medicine will be less effective over time.
The affected batch numbers are:
- 136418 (strawberry flavour)
- 136444 (strawberry flavour)
- 136443 (orange flavour)
The expiry date for each of the recalled products is February 2018.
If you have a bottle from one of the affected batches, do not use it.
Return it to the place of purchase for a refund.
If you have any questions or concerns about this issue, speak to your health professional, or call GlaxoSmithKline Consumer Healthcare Australia on 1800 028 533.
See more about the recall on the TGA website
